These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2359208)

  • 1. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M; Makita F; Takeyoshi I; Ishikawa H; Nakamura S; Owada S; Miyamoto Y; Izuo M; Kurashige S
    Jpn J Surg; 1990 May; 20(3):316-26. PubMed ID: 2359208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of RBS (rice bran saccharide) on ENNG-induced carcinogenesis.
    Takeshita M; Nakamura S; Makita F; Ohwada S; Miyamoto Y; Morishita Y
    Biotherapy; 1992; 4(2):139-45. PubMed ID: 1622734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y; Shiraishi T; Tsuchitani T; Tobe T; Sugawara Y; Saito M; Kamiyama H
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat.
    Saji S; Umemoto T; Kida H; Sakata K
    J Surg Oncol; 1985 Sep; 30(1):46-51. PubMed ID: 4079418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immunochemotherapy on lymphocyte response of patients with gastrointestinal cancer.
    Mashiba H; Yoshinaga H; Matsunaga K; Gojobori M; Furusawa M
    J Surg Oncol; 1979; 12(3):275-9. PubMed ID: 502567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prophylactic effects of a streptococcal preparation OK-432 on carcinogenesis in rats by MNNG and DMH].
    Shimizu H; Kimura S; Kiyasu Y; Toyonaga F; Sakai K; Sato M
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1029-34. PubMed ID: 7130792
    [No Abstract]   [Full Text] [Related]  

  • 9. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of gastric cancer].
    Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
    Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of polyamine fractions in rats bearing ENNG-induced carcinoma--special reference to the relationship between immunostimulants and antineoplastic activity].
    Takeyoshi I; Miyamoto Y; Takeshita M; Nakamura S; Makita F; Tago T; Izuo M
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):630. PubMed ID: 3405201
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in mice.
    Suzuki I; Kinoshita A; Tanaka H; Yadomae T
    Int J Immunopharmacol; 1991; 13(2-3):147-54. PubMed ID: 2071291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):609-17. PubMed ID: 2932509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic therapy for liver metastasis of gastrointestinal carcinomas using biological response modifiers (BRM): fundamental studies on the inhibition of experimental liver metastasis by intraportal administration of OK-432].
    Kasagi T; Tazawa K; Yamashita I; Ishizawa S; Masuyama K; Fujimaki M; Maeda M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):112-20. PubMed ID: 2324583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H; Itoh N; Tamaya T
    Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.